Growth Metrics

QuidelOrtho (QDEL) EBITDA Margin (2021 - 2024)

QuidelOrtho's EBITDA Margin history spans 3 years, with the latest figure at 83.23% for Q4 2023.

  • For Q4 2023, EBITDA Margin changed N/A year-over-year to 83.23%; the TTM value through Sep 2024 reached 93.37%, down 11571.0%, while the annual FY2024 figure was 73.96%, 7488.0% down from the prior year.
  • EBITDA Margin for Q4 2023 was 83.23% at QuidelOrtho, down from 4.04% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 82.99% in Q4 2021 and bottomed at 83.23% in Q4 2023.
  • The 3-year median for EBITDA Margin is 12.48% (2023), against an average of 19.51%.
  • The largest YoY upside for EBITDA Margin was 5300bps in 2022 against a maximum downside of -7575bps in 2022.
  • A 3-year view of EBITDA Margin shows it stood at 82.99% in 2021, then plummeted by -91bps to 7.25% in 2022, then tumbled by -1249bps to 83.23% in 2023.
  • Per Business Quant, the three most recent readings for QDEL's EBITDA Margin are 83.23% (Q4 2023), 4.04% (Q3 2023), and 11.77% (Q2 2023).